The above data is sourced from Hansoh Pharma's ESG Report 2025
-
82.2 %The proportion of revenue from innovative drugs and cooperative products to total revenue in 2024 -
42.9 %Percentage of female directors reached 42.9% -
40.73 %Progress of greenhouse gas emission reduction targets: The emissions of greenhouse gas per unit revenue 2025 (scope I and scope II) reduced by 40.73% than that in 2021 -
80 % +Employee satisfaction rate of 80% -
244,404 hoursQuality training for a total of 244,404 hours in 2025 -
91.15 %Progress of pollutant reduction: ammonia nitrogen in waste water per unit revenue 2025 reduced by 91.15% than that in 2021 -
100 %100% approval rate for product certification checks and customer audits -
48As of the end of 2025, the number of drugs had entered 48 low- and middle-income countries and regions -
